Not to be confused with cinazepam, clonazepam, or camazepam.
Clinical data
Trade names Gerodorm
AHFS/ cinolazepam
Routes of
ATC code N05CD13 (WHO)
Legal status
Legal status
Pharmacokinetic data
Bioavailability 90–100%
Metabolism Hepatic
Biological half-life 9 hours[1]
Excretion Renal
CAS Number 75696-02-5 YesY
PubChem (CID) 3033621
DrugBank DB01594 YesY
ChemSpider 2298251 YesY
UNII 68P0556B0U YesY
KEGG D07328 YesY
ChEBI CHEBI:59514 YesY
Chemical and physical data
Formula C18H13ClFN3O2
Molar mass 357.8
3D model (Jmol) Interactive image
Chirality Racemic mixture
 NYesY (what is this?)  (verify)

Cinolazepam[2] (marketed under the brand name Gerodorm)[3] is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Due to its strong sedative properties, it is primarily used as an hypnotic.

Cinolazepam is not approved for sale in the United States or Canada.

See also


  1. Saletu, B.; G. Kindshofer; P. Anderer; J. Grunberger (1987). "Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise.". International Journal of Clinical Pharmacology Research. 7 (5): 40718. PMID 2889679.
  2. US Patent 4388313 Novel 3-hydroxy-1,4-benzodiazepine-2-ones and process for the preparation thereof
  3. Lannacher Romania (1999). "Gerodorm". Produse Gerot inregistrate in Romania (in Romanian). Archived from the original on 11 October 2006. Retrieved 17 August 2006.
This article is issued from Wikipedia - version of the 11/25/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.